Abstract:Background: Lung cancer is the most common oncological cause of death in the Western world. Early diagnosis is critical for successful treatment. However, no effective screening methods exist. A promising approach could be the use of volatile organic compounds as diagnostic biomarkers. To date there are several studies, in which dogs were trained to discriminate cancer samples from controls. In this study we evaluated the abilities of specifically trained dogs to distinguish samples derived from lung cancer patients of various tumor stages from matched healthy controls. Methods: This single center, double-blind clinical trial was approved by the local ethics committee, project no FF20/2016. The dog was conditioned with urine and breath samples of 36 cancer patients and 150 controls; afterwards, further 246 patients were included: 41 lung cancer patients comprising all stages and 205 healthy controls. From each patient two breath and urine samples were collected and shock frozen. Only samples from new subjects were presented to the dog during study phase randomized, double-blinded. This resulted in a specific conditioned reaction pointing to the cancer sample. Results: Using a combination of urine and breath samples, the dog correctly predicted 40 out of 41 cancer samples, corresponding to an overall detection rate of cancer samples of 97.6% (95% CI [87.1, 99.9%]). Using urine samples only the dog achieved a detection rate of 87.8% (95% CI [73.8, 95.9%]). With breath samples, the dog correctly identified cancer in 32 of 41 samples, resulting in a detection rate of 78% (95% CI [62.4, 89.4%]). Conclusions: It is known from current literature that breath and urine samples carry VOCs pointing to cancer growth. We conclude that olfactory detection of lung cancer by specifically trained dogs is highly suggestive to be a simple and non-invasive tool to detect lung cancer. To translate this approach into practice further target compounds need to be identified.

The Research Progress of Using the Mammalian Olfaction for Cancer Diagnosis

A Study of the Volatile Organic Compounds Exhaled by Lung Cancer Cells in Vitro for Breath Diagnosis

Electronic Nose for Detecting Lung Cancer Based on Virtual Gas Sensor Array

The research on early detection of lung cancer with exhaled volatile organic compounds

The Research of Electronic Nose and Diagnosis Model for Clinical Breath Diagnosis of Lung Cancer

Lung cancer diagnosis method by detecting metabolic gases of lung cells

Development Of Electronic Nose For Diagnosis Of Lung Cancer At Early Stage

Research on Hybrid Recognition Algorithms of Lung Cancer Breath Diagnosis Based on MOS and SAW Sensors

Screening and Bioinformatics Analysis of Lung Cancer Exhale Breath Biomarkers

Optimization of Volatile Markers of Lung Cancer to Exclude Interferences of Non-Malignant Disease

Investigation and Application of Exhaled Breath Condensate Analysis in Lung Cancer

Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis

Sniffer dogs can identify lung cancer patients from breath and urine samples

Diagnosis and Correlation Analysis of Lung Cancer Based on Multi-Parameter Regression of Respiratory Volatile Organic Compounds

Recognizing lung cancer and stages using a self-developed electronic nose system

Volatile organic compounds in cancer and exhaled breath detection technology

A Study on Electronic Nose for Clinical Breath Diagnosis of Lung Cancer

A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method

An Electronic Nose Based on Hybrid MOS-SAW Sensors for Detection of Different Biomarkers of Lung Cancer

A Non-invasive Detection of Lung Cancer Combined Virtual Gas Sensors Array with Imaging Recognition Technique.

Metal Oxide Semiconductor Gas Sensors for Lung Cancer Diagnosis